Zynex (NASDAQ:ZYXI) Announces Quarterly Earnings Results

Zynex (NASDAQ:ZYXI) announced its earnings results on Thursday. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.04), Briefing.com reports. The company had revenue of $49.88 million for the quarter, compared to analyst estimates of $51.99 million. Zynex had a return on equity of 13.14% and a net margin of 3.12%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.09 earnings per share.

Zynex Stock Down 12.4 %

Zynex stock traded down $1.26 during midday trading on Friday, reaching $8.93. The stock had a trading volume of 1,034,596 shares, compared to its average volume of 124,147. Zynex has a 12 month low of $6.88 and a 12 month high of $13.77. The company has a market capitalization of $283.71 million, a P/E ratio of 38.83 and a beta of 0.53. The company has a fifty day moving average price of $9.55 and a two-hundred day moving average price of $11.06. The company has a current ratio of 3.58, a quick ratio of 2.87 and a debt-to-equity ratio of 1.76.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ZYXI. Royal Bank of Canada dropped their price objective on Zynex from $15.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday. HC Wainwright dropped their price objective on Zynex from $21.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday.

About Zynex

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device.